Stay updated on Early vs Late Consolidation for Maintenance in AML Clinical Trial
Sign up to get notified when there's something new on the Early vs Late Consolidation for Maintenance in AML Clinical Trial page.

Latest updates to the Early vs Late Consolidation for Maintenance in AML Clinical Trial page
- Check2 days agoChange DetectedThe clinical trial record for NCT03004287 is displayed, describing a Phase 2 study of daratumumab-based therapy for newly diagnosed high-risk multiple myeloma, along with participation criteria, interventions, and study timelines.SummaryDifference69%

- Check9 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA notice about NIH’s terminology transition appeared above the page, and the site revision changed from v3.7.1 to v3.7.2. The study page still displays a 403 Forbidden error.SummaryDifference1%

- Check37 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now displays a 403 Forbidden error. It replaces the study content with a minimal error notice and a Home link.SummaryDifference21%

- Check58 days agoChange Detected- The revision history was updated to include a new version tag (v3.7.0) and recent dates, indicating metadata updates to the page. The older revision tag (v3.6.6) was removed as part of the update.SummaryDifference0.5%

Stay in the know with updates to Early vs Late Consolidation for Maintenance in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Early vs Late Consolidation for Maintenance in AML Clinical Trial page.